Minerva Neurosciences Inc (NERV) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $6.23
• Market Cap: $26.92M
• EPS: $-1.85
• 52-Week High: $6.69
• 52-Week Low: $1.15

Market Sentiment

Minerva Neurosciences Inc currently has a Bullish sentiment score of 0.36.

About Minerva Neurosciences Inc

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, specializing in the development of innovative therapies for central nervous system disorders. The company’s robust pipeline targets significant unmet medical needs in neuropsychiatric conditions, emphasizing its commitment to research and development. By leveraging cutting-edge science, Minerva aims to transform treatment paradigms and improve quality of life for patients facing ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Minerva Neurosciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NERV pay dividends?

Minerva Neurosciences Inc (NERV) does not currently pay a regular dividend.

What is NERV's market cap?

Minerva Neurosciences Inc (NERV) has a market capitalization of $26.92M with a current stock price of $6.23.